$13.96
al cierre: Oct 29 EDT
$13.99
0.030.21%
Pre-comercialización: 7:31 AM EDT
Comments
Loading...
Intellia Therapeutics Informe de interés a corto plazo
NTLANASDAQ
Informe de interés en corto
El interés corto en Intellia Therapeutics Inc (NASDAQ:NTLA) ha aumentado durante el último período de informe, aumentando en aumento desde 29.74M hasta 30.90M. Esto representa el 32.61% de las acciones disponibles públicamente de la empresa.
El interés en corto en Intellia Therapeutics Corp (XNAS:NTLA) disminuyó durante el último período de informe, cayendo de 280,30 millones a 275,20 millones. Esto hizo que el 1,17 % de las acciones disponibles públicamente de la empresa se pusieran en corto.
Basado en el volumen promedio reciente de 7.35M acciones negociadas por día, tomaría 4.2 día(s) para que los poseedores de este interés corto cierren sus posiciones sin impulsar bruscamente el precio de las acciones.
Interés en corto
30.90M
Interés en corto %
32.6%
Días para cubrir
4.2
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
NTLA | Intellia Therapeutics, Inc. Co | 10/15/2025 | 10/24/2025 | 32.61% | 94,763,719 | 30,904,192 | 7,353,538 | 4.2 | |
NTLA | Intellia Therapeutics, Inc. Co | 09/30/2025 | 10/09/2025 | 31.38% | 94,763,719 | 29,739,035 | 8,171,291 | 3.64 | |
NTLA | Intellia Therapeutics, Inc. Co | 09/15/2025 | 09/24/2025 | 36.02% | 94,763,719 | 34,137,856 | 4,330,394 | 7.88 | |
NTLA | Intellia Therapeutics, Inc. Co | 08/29/2025 | 09/10/2025 | 29.27% | 94,763,719 | 27,737,890 | 3,669,340 | 7.56 | |
NTLA | Intellia Therapeutics, Inc. Co | 08/15/2025 | 08/26/2025 | 29.26% | 94,763,719 | 27,729,214 | 4,868,956 | 5.7 | |
NTLA | Intellia Therapeutics, Inc. Co | 07/31/2025 | 08/11/2025 | 31.35% | 94,763,719 | 29,708,601 | 5,014,474 | 5.92 | |
NTLA | Intellia Therapeutics, Inc. Co | 07/15/2025 | 07/24/2025 | 31.72% | 91,000,227 | 28,867,302 | 4,661,964 | 6.19 | |
NTLA | Intellia Therapeutics, Inc. Co | 06/30/2025 | 07/10/2025 | 33.11% | 91,000,227 | 30,130,358 | 4,907,825 | 6.14 | |
NTLA | Intellia Therapeutics, Inc. Co | 06/13/2025 | 06/25/2025 | 32.63% | 91,000,227 | 29,689,496 | 5,037,494 | 5.89 | |
NTLA | Intellia Therapeutics, Inc. Co | 05/30/2025 | 06/10/2025 | 34.68% | 91,000,227 | 31,557,488 | 6,136,529 | 5.14 | |
NTLA | Intellia Therapeutics, Inc. Co | 05/15/2025 | 05/27/2025 | 33.74% | 91,000,227 | 30,704,048 | 3,534,966 | 8.69 | |
NTLA | Intellia Therapeutics, Inc. Co | 04/30/2025 | 05/09/2025 | 31.59% | 91,000,227 | 28,748,798 | 2,995,848 | 9.6 | |
NTLA | Intellia Therapeutics, Inc. Co | 04/15/2025 | 04/25/2025 | 31.30% | 91,085,914 | 28,509,745 | 3,935,301 | 7.24 | |
NTLA | Intellia Therapeutics, Inc. Co | 03/31/2025 | 04/09/2025 | 29.57% | 91,085,914 | 26,937,869 | 3,461,771 | 7.78 | |
NTLA | Intellia Therapeutics, Inc. Co | 03/14/2025 | 03/25/2025 | 29.30% | 91,085,914 | 26,688,670 | 3,107,843 | 8.59 | |
NTLA | Intellia Therapeutics, Inc. Co | 02/28/2025 | 03/11/2025 | 28.58% | 91,085,914 | 26,035,739 | 4,291,777 | 6.07 | |
NTLA | Intellia Therapeutics, Inc. Co | 02/14/2025 | 02/26/2025 | 27.31% | 89,417,026 | 24,418,372 | 2,602,497 | 9.38 | |
NTLA | Intellia Therapeutics, Inc. Co | 01/31/2025 | 02/11/2025 | 26.90% | 89,417,026 | 24,057,390 | 2,940,809 | 8.18 | |
NTLA | Intellia Therapeutics, Inc. Co | 01/15/2025 | 01/27/2025 | 26.91% | 89,417,026 | 24,060,839 | 3,313,752 | 7.26 | |
NTLA | Intellia Therapeutics, Inc. Co | 12/31/2024 | 01/10/2025 | 24.23% | 89,417,026 | 21,668,143 | 2,467,818 | 8.78 | |
NTLA | Intellia Therapeutics, Inc. Co | 12/13/2024 | 12/24/2024 | 22.15% | 89,417,026 | 19,807,004 | 2,117,088 | 9.36 | |
NTLA | Intellia Therapeutics, Inc. Co | 11/29/2024 | 12/10/2024 | 21.15% | 89,417,026 | 18,914,793 | 3,246,797 | 5.83 | |
NTLA | Intellia Therapeutics, Inc. Co | 11/15/2024 | 11/26/2024 | 18.30% | 89,417,026 | 16,365,436 | 2,530,308 | 6.47 | |
NTLA | Intellia Therapeutics, Inc. Co | 10/31/2024 | 11/11/2024 | 18.06% | 89,417,026 | 16,151,411 | 3,322,227 | 4.86 | |
NTLA | Intellia Therapeutics, Inc. Co | 10/15/2024 | 10/24/2024 | 18.35% | 89,147,642 | 16,360,769 | 1,868,829 | 8.75 | |
NTLA | Intellia Therapeutics, Inc. Co | 09/30/2024 | 10/09/2024 | 16.99% | 89,147,642 | 15,142,172 | 1,533,472 | 9.87 | |
NTLA | Intellia Therapeutics, Inc. Co | 09/13/2024 | 09/24/2024 | 16.56% | 89,147,642 | 14,759,250 | 1,368,514 | 10.78 | |
NTLA | Intellia Therapeutics, Inc. Co | 08/30/2024 | 09/11/2024 | 15.37% | 89,147,642 | 13,703,315 | 977,317 | 14.02 | |
NTLA | Intellia Therapeutics, Inc. Co | 07/31/2024 | 08/09/2024 | 15.00% | 89,147,642 | 13,370,113 | 1,473,944 | 9.07 | |
NTLA | Intellia Therapeutics, Inc. Co | 07/15/2024 | 07/24/2024 | 16.48% | 84,043,875 | 13,848,364 | 1,516,358 | 9.13 | |
NTLA | Intellia Therapeutics, Inc. Co | 06/28/2024 | 07/10/2024 | 15.77% | 84,043,875 | 13,251,610 | 2,266,513 | 5.85 | |
NTLA | Intellia Therapeutics, Inc. Co | 06/14/2024 | 06/26/2024 | 16.35% | 84,043,875 | 13,741,636 | 1,897,200 | 7.24 | |
NTLA | Intellia Therapeutics, Inc. Co | 05/31/2024 | 06/11/2024 | 17.49% | 84,043,875 | 14,695,539 | 1,499,221 | 9.8 | |
NTLA | Intellia Therapeutics, Inc. Co | 05/15/2024 | 05/24/2024 | 18.05% | 84,043,875 | 15,167,458 | 1,452,817 | 10.44 | |
NTLA | Intellia Therapeutics, Inc. Co | 04/30/2024 | 05/09/2024 | 18.37% | 84,043,875 | 15,439,289 | 1,141,639 | 13.52 | |
NTLA | Intellia Therapeutics, Inc. Co | 04/15/2024 | 04/24/2024 | 17.37% | 84,007,062 | 14,590,490 | 1,260,973 | 11.57 | |
NTLA | Intellia Therapeutics, Inc. Co | 03/28/2024 | 04/09/2024 | 17.29% | 85,789,397 | 14,833,304 | 1,071,483 | 13.84 | |
NTLA | Intellia Therapeutics, Inc. Co | 03/15/2024 | 03/26/2024 | 15.74% | 85,789,397 | 13,502,755 | 1,539,986 | 8.77 | |
NTLA | Intellia Therapeutics, Inc. Co | 02/29/2024 | 03/11/2024 | 14.71% | 85,789,397 | 12,616,622 | 2,336,086 | 5.4 | |
NTLA | Intellia Therapeutics, Inc. Co | 02/15/2024 | 02/27/2024 | 13.55% | 85,789,397 | 11,626,877 | 1,674,215 | 6.94 | |
NTLA | Intellia Therapeutics, Inc. Co | 01/31/2024 | 02/09/2024 | 13.85% | 79,237,883 | 10,971,169 | 1,436,577 | 7.64 | |
NTLA | Intellia Therapeutics, Inc. Co | 01/12/2024 | 01/24/2024 | 13.19% | 79,237,883 | 10,451,029 | 1,358,418 | 7.69 | |
NTLA | Intellia Therapeutics, Inc. Co | 12/29/2023 | 01/10/2024 | 12.83% | 79,237,883 | 10,163,815 | 1,376,353 | 7.38 | |
NTLA | Intellia Therapeutics, Inc. Co | 12/15/2023 | 12/27/2023 | 13.25% | 79,237,883 | 10,500,937 | 1,712,386 | 6.13 | |
NTLA | Intellia Therapeutics, Inc. Co | 11/30/2023 | 12/11/2023 | 12.44% | 79,237,883 | 9,854,501 | 1,450,801 | 6.79 | |
NTLA | Intellia Therapeutics, Inc. Co | 11/15/2023 | 11/27/2023 | 11.96% | 79,237,883 | 9,474,918 | 1,850,347 | 5.12 | |
NTLA | Intellia Therapeutics, Inc. Co | 10/31/2023 | 11/09/2023 | 12.31% | 78,173,942 | 9,625,691 | 1,436,243 | 6.7 |
En busca de los valores más cortos?